Sensus Healthcare (SRTS) Cash & Equivalents (2015 - 2026)

Sensus Healthcare's Cash & Equivalents history runs 12 years deep, the most recent figure standing at $18.3 million for Q1 2026.

• On a quarterly basis, Cash & Equivalents fell 3.91% year-over-year to $18.3 million in Q1 2026; TTM through Mar 2026 was $18.3 million, a 3.91% decrease from a year earlier, with the FY2025 full-year figure at $22.1 million, changed 0.12% from the prior year.
• Cash & Equivalents eased to $18.3 million in Q1 2026 per SRTS's latest filing, from $22.1 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $37.6 million in Q3 2022 and bottomed at $14.7 million in Q1 2024.
• The 5-year median for Cash & Equivalents is $22.1 million (2025), against an average of $23.4 million.
• Across the five-year window, Cash & Equivalents jumped 140.48% in 2022 and tumbled 45.48% in 2023, its largest moves.
• Year by year, Cash & Equivalents stood at $25.5 million in 2022, then declined by 9.29% to $23.1 million in 2023, then decreased by 4.72% to $22.1 million in 2024, then rose by 0.12% to $22.1 million in 2025, then fell by 17.01% to $18.3 million in 2026.
• Per Business Quant, the three latest SRTS Cash & Equivalents figures stand at $18.3 million (Q1 2026), $22.1 million (Q4 2025), and $24.5 million (Q3 2025).